Launching the World’s First Pure CBDV Oil
Rare Cannabinoid Company has launched world’s first pure CBDV oil. CBDV (cannabidivarin) joins our apothecary of cannabinoids THCV, Delta-8-THC, CBN, CBG, CBC, CBDA and full spectrum Rare Hawaiian CBD. CBDV may sound like CBD, but this varin is extremely rare and has exciting potential.
CBDV is currently being formulated into a pharmaceutical drug to reduce or eliminate seizures. There are also multiple pre-clinical and clinical studies being conducted on CBDV and inflammation, nausea, Autism Spectrum Disorder (including a study on children with autism), Muscular Dystrophy and Rett Syndrome.
What is CBDV?
CBDV is a non-psychoactive rare cannabinoid that is similar to CBD (cannabidiol) but has some key differences.
Like THCV (tetrahydrocannabidivarin), CBDV is a varin. Varins contain two fewer carbon atoms than their non-varin counterparts (THC and CBD). These differences mean that they interact with the human endocannabinoid system in different ways and have unique physiological effects.
CBDV naturally occurs in much smaller quantities than CBD and is therefore more difficult to isolate. Rare Cannabinoid Company is first to bring a pure CBDV product to market.
What is CBDV good for?
Autism Spectrum Disorder (ASD): One of the most interesting areas that CBDV is being studied for is its potential effects on Autism Spectrum Disorder (ASD). ASD is a developmental condition that impairs communication, social interaction and features repetitive movements. There is currently no approved treatment for the core symptoms of ASD, but new research shows that altered endocannabinoid signaling and immune problems may contribute to ASD.
This experiment tested CBDV treatment on a model of ASD in rats. Scientists found that “cannabidivarin treatment ameliorates autism-like behaviors and restores hippocampal endocannabinoid system and glia alterations.” In other words, CBDV improved the rats’ social skills and short-term memory, while reducing their repetitive behaviors and hyperlocomotion (constant moving as a result of excessive stimulation of the nervous system.)
CBDV is now being tested on children to see if it can reduce irritability. See the study here.
Rett Syndrome: CBDV shows promise in aiding neurobehavioral issues associated with Rett syndrome. In this study, CBDV was found to be beneficial for memory, neurological and social deficits related to Rett syndrome.
Muscular Dystrophy: CBDV was found to reduce inflammation and enhance muscle function in this study on Duchenne muscular dystrophy (DMD). Duchenne muscular dystrophy is the most common form of the muscle-wasting disease. The study found that in addition to CBDV, CBD and THCV may also prevent muscle degeneration in DMD patients.
Nausea: CBDV shows potential in reducing nausea in this study.
Inflammation: This experiment tested CBDV against ulcerative colitis in mice and in biopsies from children and found that CBDV reduced intestinal inflammation.
Seizures: CBDV is currently being developed into a pharmaceutical drug designed to reduce or prevent seizures by GW Pharmaceuticals. The British company previously developed Epidiolex, a CBD drug for seizures.
How to take CBDV
Our CBDV oil tincture contains 500mg CBDV in certified organic MCT coconut oil. Each spray contains 6.7mg CBDV and we recommend that people take one to two sprays up to two times per day.
We designed our apothecary of cannabinoid oil tinctures so that people can mix and match different single extracts of cannabinoids with each other and/or with our full spectrum Rare Hawaiian CBD. Each cannabinoid is believed to offer very different effects and we believe that this is the best way for people to be able to create their own customized blend.
For example, THCV (tetrahydrocannabivarin) acts like a stimulant increasing energy levels while decreasing appetite. CBN (cannabinol) has more relaxing, sedative effects and is an ideal addition to one’s nightly routine. Like CBDV, CBDA (cannabidiolic acid) and CBG (cannabigerol) are being studied for their therapeutic potential. Leafly, the world’s largest cannabis information website, has this article on CBG: “Is CBG better than CBD and THC for pain, inflammation, and aging?” Hemp-derived Delta-8-THC also offers many of the therapeutic effects as cannabis-derived THC but can also be intoxicating. CBC raises levels of the brain’s bliss chemical anandamide and is therefore believed to improve mood.
Please take a look at our blogs and product descriptions for more information on each cannabinoid and links to scientific studies. For more personalized advice, we have a Cannabinoid Expert Advice map that lists cannabinoid health advisors near you. Type in your zipcode in the box to narrow down to your area.
These clinics have worked with Rare Cannabinoid Company products and are knowledgeable about cannabis, hemp, specific cannabinoids, terpenes, blends and associated medical research. They can advise you on the best ways that cannabis can help you with your condition.
Many do tele-appointments if you can’t visit the clinic directly. As each works differently, to get started please search their name in Google to visit their website to setup an appointment or ask questions.
(Rare Cannabinoid Company does not endorse any clinic or treatment. We are simply referring you and have no access to your consultation.)